Neurology, Neurosurgery and Stroke

Deborah Zelinsky, O.D., F.N.O.R.A., F.C.O.V.D. is the executive director of the Mind-Eye Institute, an organization dedicated to bridging the gap between 21st century neuroscience discoveries and 20th century methods of eyecare diagnosis and treatment. During the past thirty years, she has developed methods to assess brain function, testing the overlooked linkage between eyes and ears. She is a frequent grant reviewer and consults internationally. She also presents workshops discussing how the retina is comprised of brain tissue. In 2013, she was presented with the Neuro-Optometric Rehabilitation Association’s Founding Father’s Award. Along with Donalee Markus, Ph.D, Dr. Zelinsky is featured in the 2015 book “The Ghost in My Brain: How a Concussion Stole My Life and the New Science of Brain Plasticity Brought it Back” by Dr. Clark Elliott. She is also cited in the afterword of Norman Doidge’s 2016 paperback New York Times Best Seller, “The Brain’s Way of Healing.”

Deborah Zelinsky, O.D., F.N.O.R.A., F.C.O.V.D. is the executive director of the Mind-Eye Institute, an organization dedicated to bridging the gap between 21st century neuroscience discoveries and 20th century methods of eyecare diagnosis and treatment. During the past thirty years, she has developed methods to assess brain function, testing the overlooked linkage between eyes and ears. She is a frequent grant reviewer and consults internationally. She also presents workshops discussing how the retina is comprised of brain tissue. In 2013, she was presented with the Neuro-Optometric Rehabilitation Association’s Founding Father’s Award. Along with Donalee Markus, Ph.D, Dr. Zelinsky is featured in the 2015 book “The Ghost in My Brain: How a Concussion Stole My Life and the New Science of Brain Plasticity Brought it Back” by Dr. Clark Elliott. She is also cited in the afterword of Norman Doidge’s 2016 paperback New York Times Best Seller, “The Brain’s Way of Healing.”

Dr. Tezapsidis is the founder of Neurotez, Inc. and has been the President, Chief Executive Officer and Chairman of the Board of Directors since the company was incorporated in 2005. Nikolaos raised funds through non-dilutive capital sources while building the company, recruiting top talent, maintaining top notch research and development programs and establishing a strong patent portfolio. A few years ago he negotiated a milestone-linked $100 million deal exclusive for China and a partnership with Memtrax for a new memory screening test for Alzheimer’s patients. Currently Neurotez is raising funds for clinical trials testing leptin to treat Alzheimer’s. Recipient of two awards from the Alzheimer’s Association, USA and fellowships from the Wellcome Trust and the Science and Engineering Council, UK. He has several patents issued and pending both in the US and in foreign markets and is the author of more than fifty publications. Dr. Tezapsidis received a Bachelor of Science in Chemistry from the Aristotle University, Greece and completed his Master of Science and Doctor of Philosophy in Biochemistry at the University of Sussex, UK. Nik has been interviewed by The National Herald (http://www.thenationalherald.com/?s=tezapsidis), BioCenturyTV, 1800LiveRadioInterview, and Ellines (https://www.ellines.com/en/category/famous-greeks/ ).

Alzheimer’s ,obesity and/or the metabolic syndrome that modulate brain aging...

The author received an honorable PhD in mathematics and majored in engineering at MIT. He attended different universities over 17 years and studied seven academic disciplines. He has spent 20,000 hours in T2D research. First, he studied six metabolic diseases and food nutrition during 2010 to 2013, then conducted his own diabetes research during 2014 to 2018. His approach is “quantitative medicine” based on mathematics, physics, optical and electronics physics, engineering modeling, signal processing, computer science, big data analytics, statistics, machine learning, and artificial intelligence. His main focus is on preventive medicine using prediction tools. He believes that the better the prediction, the more control you have.

The author received an honorable PhD in mathematics and majored in engineering at MIT. He attended different universities over 17 years and studied seven academic disciplines. He has spent 20,000 hours in T2D research. First, he studied six metabolic diseases and food nutrition during 2010 to 2013, then conducted his own diabetes research during 2014 to 2018. His approach is “quantitative medicine” based on mathematics, physics, optical and electronics physics, engineering modeling, signal processing, computer science, big data analytics, statistics, machine learning, and artificial intelligence. His main focus is on preventive medicine using prediction tools. He believes that the better the prediction, the more control you have.

Prof. Ivet Borissova Koleva is a medical doctor, specialist in Neurology and in Physical & Rehabilitation Medicine (PRM); with 30 years of clinical practice in the domain of Neurorehabilitation. She has completed a PhD thesis on ‘Physical Prevention and Therapy of Diabetic Polyneuropathy’; and a thesis for Doctor-es-Medical Sciences on ‘Neurorehabilitation in patients with socially important neurological diseases’. She received the titles of Associate professor (2006) and Professor (2010) in PRM. Actually, she works as a professor in the Medical University of Sofia, Bulgaria.

NeuroRehabilitation, Neurology,Polyneuropathy....

Weijian Bei has completed his PhD at 2004 from Sun Yatsen University. He is the Profeessor and Chief Scientifical Officer, Institute of Chinese Medicinal Sciences, Guangdong Pharmaceutical University, Guangzhou, China. Completed 1 key projects of national natural science foundation of China, 2 Chinese national major new drug projects,3 Guangdong province major projects and other 30 items of province level research projects, in the Chinese medicine for the control and prevention of cerebrovascular disease and senile degenerative brain disease and metabolic disease. He have good accomplishment to develop innovative Chinese medicine -Wushen Xingnao pill(WSXN), with 11 authorized China invention patent, 1 US authorized invention patents and 1 Europe authorized invention patents and 5 PCT, One of his developed Chinese patent medicine,Naoxinqin tablet, The sales exceeded 20 Billion yuan. He has published more than 80 papers in reputed journals and has been serving as an editorial board member of repute (JICM).

Clinical Trails, Chinese Medicine, Neurology

Dr. Gustavo Adolfo Uriza completed his medical degree in 1992 and then his neurosurgical training in 1998 at the same University. He has specialized studies in Colombia in vascular, tumor, trauma and spine surgery. He is the director of the Universidad de La Sabana School of Medicine since 2008. He has performed over 5000 surgical procedures during his career, serves as President of Bogotá region at the Colombian Association of Neurosurgery and has published several papers in local and regional journals

vascular, tumor, trauma and spine surgery.

Laura Cancedda graduated in Medicinal Chemistry at the University of Genoa in 1999, with a thesis on the role of neurotrophic factors on neurotransmitter release. She received her Ph.D. in neurophysiology from Scuola Normale Superiore (Pisa, Italy) in 2003, under the supervision of Dr Maffei. In Pisa, she investigated the molecular and environmental basis of experience-dependent plasticity in the rat brain. In 2003, she moved to University of California at Berkeley in Dr Poo’s laboratory where she focused her studies on molecular mechanisms of GABAergic-transmission modulation. Currently, she holds a team-leader position at the Italian Institute of Technology (IIT) in Genoa (2008- ) and a scientist position at the Telethon Dulbecco Institute, Italy (2016- ). Her research focuses on the role of extracellular factors in migration, morphological maturation and wiring of cortical neurons under physiological as well as pathological conditions. Laura has also an interest in investigating new approaches for in vivo transfection of nucleic acids

The goal of my laboratory is to understand the molecular determinants of cortical circuit development and wiring in physiology and pathology. In particular, a main focus of the laboratory is to try to understand how diverse developing neurons influence one another during neuronal migration, axon and dendrite polarization, and formation of neuronal networks. Indeed, we believe that the extracellular milieu of a specific developing brain cell is strongly influenced by the presence of other cells that are developing themselves (cellular environment). Notably, as development is by definition a dynamic process, the cellular environment will constantly change over time and it will be different in different brain areas. This may have tremendous conceptual consequences for the treatment of neurodevelopmental disorders, and we believe that the study of the different cellular environments during brain development may eventually lead to the identification of specific therapeutic windows to address aberrant neuronal development with much reduced side effects. To address these issues, we have developed two lines of research in the laboratory: a first line focuses on basic and translational animal research on brain development in health and animal models of neurodevelopmental disorders, and a second one focuses on promoting new technological approaches in developmental neuroscience.

Mohamed Abd elmonem Gohary Damanhour National Medical Institutet Alexandria 12 Tarroty st. Loran Alexandria Egypt

Neurosurgery

Vladimir Rendevski has completed his MD degree in 2004 at the ‘‘Ss. Cyril and Methodius’’ University, Skopje, specializing Neurosurgery during the period of 2005 – 2010. He was working as Assistant of surgery at the University “Ss. Kliment Ohridski” - Bitola, and later he moved to the University Clinic of Neurosurgery, Skopje, working as Neurosurgeon. Currently, he is the director of the University Clinic of Neurosurgery and he is finishing his PhD thesis in the field of biochemical, radiological and clinical prognostic factors in Intracerebral hemorrhage at The University of Nis, Serbia. He has published papers in reputed journals and has been serving as an editorial board member of repute."

University ,,St. Kliment Ohridski”-Bitola, High medical school-Bitola 2005-2006 Assistant of surgery 2. Clinical hospital ,,D-r Trifun Panovski”-Bitola, Department of neurosurgery, University clinic of neurosurgery-Skopje 2005-2010 Specialization of neurosurgery, MD 3. Clinical hospital ,,D-r Trifun Panovski”-Bitola, Department of neurosurgery 2010-2012 Neurosurgeon, MD 4. University clinic of neurosurgery-Skopje 2012- Neurosurgeon, MD Meetings: Congresses, Conferences, Symposiums, Expert

Toshimitsu Musha right after he retired from Tokyo Institute of Technology, aiming at developing new EEG analysis technologies for non-invasively estimating signal processing in the brain. The first target was prevention of the sudden death coming from the mental overwork of workaholic people. Eventually he has reached a new technique of reading a dynamic change of our mind. This technique expresses the emotional state as an emotion vector in the 4-D rectangular coordinate system spanned by four orthogonal sates: stress, joy, depression, and relaxation. This technique has been named ESAM for Emotion Spectrum Analysis Method. This is now widely used in industries for measuring the degree of satisfaction of users of their new products and for objective evaluation of our living environments.

Alzheimer's disease, Dementia

I have an experience of Neurosurgery for 9 years in educational hospitals, studying MD of Neurosurgery cairo university,Msc of Neurosurgery , member of ESA os spine,member of ESNS of neurosurgeons, alot of conferences about Neurosurgery and spine Administrator of Egyptian&World Neurosurgeons®Community on telegram

Neurolgy, Neurosurgeons Telegram head, Neurosurgeon

Dr. George Perry is currently the dean of the College of Sciences and professor of biology at the University of Texas at San Antonio. After graduation in Zoology from University of California, Santa Barbara, he headed to Scripps Institution of Oceanography and also studied at Hopkins Marine Station of Stanford University and the Marine Biological Laboratory of Woods Hole and obtained his PhD in Marine Biology in 1979. Dr. Perry joined the faculty of Case Western Reserve University in 1995, where he currently holds an adjunct appointment. He is a Fellow of the American Association for the Advancement of Sciences, Microscopy Society of America, Royal Society of Medicine, Royal Society of Chemistry, Society of Biology and the Linnean Society and past-president of the American Association of Neuropathologists. He has been elected member of the Spanish Royal Academy of Sciences, Mexican Academy of Sciences and Academy of Sciences Lisbon; Iberoamerican Molecular Biology Organization, Dana Alliance for Brain Initiatives and won the Distinguished Professional Mentor Award from the Society for the Advancement of Chicanos and Native Americans in Science, Senior Investigator Award from the International College of Geriatric psychoneuropharmacology, Senior Fulbright Fellow and the National Honor Plaque of Panama for exceptional contributions to Neuroscience. Dr. Perry is on Board of the National Organization of Portuguese Americans and serves as Director of Education and Research.

Dr. George Perry is currently the dean of the College of Sciences and professor of biology at the University of Texas at San Antonio. After graduation in Zoology from University of California, Santa Barbara, he headed to Scripps Institution of Oceanography and also studied at Hopkins Marine Station of Stanford University and the Marine Biological Laboratory of Woods Hole and obtained his PhD in Marine Biology in 1979. Dr. Perry joined the faculty of Case Western Reserve University in 1995, where he currently holds an adjunct appointment. He is a Fellow of the American Association for the Advancement of Sciences, Microscopy Society of America, Royal Society of Medicine, Royal Society of Chemistry, Society of Biology and the Linnean Society and past-president of the American Association of Neuropathologists. He has been elected member of the Spanish Royal Academy of Sciences, Mexican Academy of Sciences and Academy of Sciences Lisbon; Iberoamerican Molecular Biology Organization, Dana Alliance for Brain Initiatives and won the Distinguished Professional Mentor Award from the Society for the Advancement of Chicanos and Native Americans in Science, Senior Investigator Award from the International College of Geriatric psychoneuropharmacology, Senior Fulbright Fellow and the National Honor Plaque of Panama for exceptional contributions to Neuroscience. Dr. Perry is on Board of the National Organization of Portuguese Americans and serves as Director of Education and Research.